Legal News Articles - Defective Products
November 8, 2017. By Jane Mundy.
Decatur, IL: Litigation involving Essure is taking its toll on Bayer. In less than a year, the permanent birth control device manufacturer has seen lawsuits more than double, and it has been removed from every global market, except in the U.S.Read [ Bayer Reports Spike in Essure Lawsuits and Congress Questions FDA ]
November 7, 2017. By Anne Wallace.
Washington, DC How is this possible when few, if any, Actemra lawsuits have even been filed yet? The answer lies in the tried-and-true defense pharmaceutical companies, like Roche and its subsidiary Genentech, will reach for first: the statute of limitations. The best thing a potential plaintiff can do is to file a lawsuit as soon as possible. Don’t wait.Read [ Time Runs Short for Actemra Lawsuits ]
November 6, 2017. By Lucy Campbell.
Philadelphia, PA: Allegations of witness tampering have stalled the beginning of the Xarelto litigation. The first Xarelto trail was set to being Monday, November 6, but instead got sidelined by attempts to determine the significance of a meeting between a key witness, Dr. Timothy Aldridge, the plaintiff’s treating physician, and a Janssen sales representative.Read [ First Xarelto Trial Stalled Over Allegations of Witness Tampering ]
November 5, 2017. By Gordon Gibb.
New York, NY: A Mirena side effects lawsuit filed late last month accuses the manufacturer of the popular IUD of not doing enough to warn consumers about the potential for pseudotumor cerebri, or PTC, associated with the long-term birth control device. According to Court records the plaintiff has suffered from vision problems and a build-up of fluid since acquiring the device.Read [ Mirena IUD Lawsuit Alleges Grievous Mirena IUD Side Effects ]
November 4, 2017. By Anne Wallace.
San Francisco, CA: On October 11, 2017, a group of Onglyza plaintiffs filed a Motion to Transfer with the U.S. Judicial Panel on Multidistrict Litigation (JPML). The motion seeks to consolidate the Onglyza lawsuits filed throughout the federal court system in the U.S. District Court for the Northern District of California. At the time of filing, there were 44 lawsuits pending in 24 federal jurisdictions, all of which put forth virtually identical legal and factual theories. Plaintiffs foresee the possibility that hundreds of Onglyza and Kombiglyze (collectively referred to as “Onglyza” in the motion) lawsuits will be filed in the future.Read [ Onglyza Lawsuits Seek MDL Status in California ]
November 4, 2017. By Gordon Gibb.
Atlanta, GA: Ethicon Physiomesh may be off the market at the behest of its manufacturer, but that hasn’t stemmed the flood of lawsuits that have been piling up in multidistrict litigation. In this case, the surgical mesh lawsuit has been filed by a plaintiff with the surname Flood.Read [ Texas Plaintiff Joins Flood of Lawsuits Citing Ethicon Physiomesh Problems ]
November 4, 2017. By Jane Mundy.
Santa Clara, CA: The number of catheters reported to be defective over the last few years is mind-boggling. Over the past year alone several medical device manufacturers have recalled a combined four million catheters. Why so many? A study published yesterday may give one explanation.Read [ Unnecessary and Defective Catheter? ]
November 1, 2017. By Anne Wallace.
Camden, NJ: Daiichi Sankyo’s recent $300 million Benicar lawsuit settlement will end the story for some who were hurt by the blood pressure drug. But it will leave others out in the cold.Read [ Left Behind in Benicar Lawsuit Settlement ]
November 1, 2017. By Jane Mundy.
Chino, CA: When Marisa received an “Important Medical Device Advisory” letter from St. Jude Medical announcing that her implantable cardiac defibrillator may contain batteries that could run out sooner than expected, she was concerned, to say the least. Since she was 12 years old, Marisa, age 31, has depended upon a pacemaker to keep her alive.Read [ Heart Patient Fears for Her Life Living with Recalled St. Jude Pacemaker ]
Court Documents Reveals J&J Transvaginal Mesh Marketed Ahead of Competitors “Priceless”, Causing Outrage Overseas
October 31, 2017. By Jane Mundy.
London, UK: Politicians and Professors of medicine in the U.K. are condemning the decision to launch transvaginal mesh without a clinical trial and demanding a public inquiry into the mesh.Read [ Court Documents Reveals J&J Transvaginal Mesh Marketed Ahead of Competitors “Priceless”, Causing Outrage Overseas ]
- Attorneys Investigating Actemra Complaints and its Approval Process By Jane Mundy (Oct-31-17)
- Mesothelioma Victims and Their Families Win Lawsuits against Insulation Supplier By Brenda Craig (Oct-31-17)
- Six Sue Tristar for Exploding Pressure Cooker Injuries By Anne Wallace (Oct-29-17)
- Rumors of Doom for Talcum Powder Lawsuits Greatly Exaggerated By Anne Wallace (Oct-29-17)
- Asbestos and Environmental Law By Gordon Gibb (Oct-28-17)
- You Can Easily Trace a Car’s History, but Not Necessarily Their Parts By Gordon Gibb (Oct-27-17)
- Stockert 3T Bacterial Infection Can Linger By Jane Mundy (Oct-27-17)
- Gynecomastia Risperdal Plaintiff Wins First Lawsuit Outside Philadelphia Court By Jane Mundy (Oct-27-17)
- Hip Replacement led to Sleep Deprivation and Oxycodone By Jane Mundy (Oct-26-17)
- Monsanto Moves for Summary Judgement While EU Looks to Ban Glyphosate By Gordon Gibb (Oct-23-17)
- $417 Jury Verdict Tossed in California J&J Ovarian Cancer Lawsuit By Lucy Campbell (Oct-23-17)
- Will Duodenoscope Redesign Prove Sufficient to Stem Endoscope Infection? By Gordon Gibb (Oct-22-17)
- Criticism for Both St. Jude Medical and FDA over Defective St. Jude ICD Batteries By Gordon Gibb (Oct-20-17)
- Second Recall for Mitsubishi Airbags By Anne Wallace (Oct-20-17)
- Research Both Kind, and Unkind to Propecia By Gordon Gibb (Oct-19-17)
- Cook Celect IVC Filters Approved Through FDA Fast Track Approval Process By Gordon Gibb (Oct-18-17)
- $72M J&J Talc Cancer Verdict Reversed By Lucy Campbell (Oct-18-17)
- As Eliquis Lawsuits Fall, New Study Heightens Bleeding Risk in Eliquis Class By Gordon Gibb (Oct-17-17)
- Airbag Attorney Urges Everyone to Check their Vehicles—You May Be in Danger By Jane Mundy (Oct-17-17)
- Depuy Attune Knee Victim “Pissed off that there’s No Way to Fix this Defect Without Litigation” By Jane Mundy (Oct-16-17)
- Medtronic SynchroMed Infusion Pump: a History of Problems By Gordon Gibb (Oct-15-17)
- Is Abdominal Mesh Overused? By Gordon Gibb (Oct-14-17)
- Mesothelioma and Ovarian Cancer Talc Lawsuits Have in Common the Talc Supplier By Jane Mundy (Oct-14-17)
- Are Actemra Claimants Headed for Multidistrict Litigation? By Anne Wallace (Oct-13-17)
- East Texas County Joins Legal War Against Opioid Manufacturers By Brenda Craig (Oct-12-17)
- Hyundai Appears to Have Escaped the Horror of Takata Air Bags, Others Not So Lucky By Gordon Gibb (Oct-11-17)
- Court Order Means Potential Taxotere Plaintiffs Should Act ASAP By Anne Wallace (Oct-11-17)
- New York State Risperdal Plaintiff Awarded $1 Million By Gordon Gibb (Oct-11-17)
- Bayer Bans Essure Outside US, Is FDA Lagging? By Jane Mundy (Oct-10-17)
- Cook Celect IVC Filter Lawsuit Goes to Trial By Anne Wallace (Oct-9-17)
- Second Testosterone Bellwether Lawsuit Wraps in Illinois By Gordon Gibb (Oct-9-17)
- Were Defective St. Jude Cardiac Defibrillators Implanted Even After Recall? By Anne Wallace (Oct-9-17)
- Add Pancreatic Cancer to Your List of Saxagliptin Worries By Anne Wallace (Oct-9-17)
- The Recalled Fetch 2 Aspiration Catheter Received FDA 510(k) Clearance By Gordon Gibb (Oct-8-17)
- Monsanto’s Roundup Cancer Lawsuits Reveal Cover-Up and the Monsanto Plot Thickens… By Jane Mundy (Oct-7-17)
- Plaintiff Alleges Nexium Caused Kidney Problems By Brenda Craig (Oct-7-17)
- Transvaginal Mesh “Like Being Cut with a Cheese Wire” By Gordon Gibb (Oct-3-17)
- Smith & Nephew Defective Knee Replacements Under the Microscope By Gordon Gibb (Oct-2-17)
- New Invokana Research (Funded by Manufacturer) Disputes Earlier Studies Showing Amputation Risk By Jane Mundy (Oct-2-17)
- J&J Seeks Judgment Notwithstanding the Verdict in Talcum Powder Lawsuit By Anne Wallace (Sep-30-17)